Cardiovascular Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
J Interv Cardiol. 2021 Mar 16;2021:6619503. doi: 10.1155/2021/6619503. eCollection 2021.
For decades, cardiovascular diseases (CVD) have been known as men's disease. However, recent research studies showed that they have become more common in women. Smoking is a strong risk factor for CVD especially that of coronary artery disease (CAD). Several studies reported that women are more susceptible to drastic sequels of smoking than men. There is limited data regarding the impact of smoking on post-revascularization clinical events stratified by gender. This study aimed to investigate if gender significantly changes the incidence of adverse clinical outcomes after percutaneous coronary intervention (PCI) among those with history of smoking.
Participants were selected from two hospitals from 2003 to 2019. Among patients who had PCI (index PCI), those with stable CAD who underwent elective PCI were included. Exclusion criteria were defined as primary PCI and those with multiple prior revascularizations. Participants were followed up seeking for major adverse cardiac events (MACE) including revascularization (PCI or coronary artery bypass grafting), myocardial infarction, and coronary death in three time intervals according to the time of index PCI (short term: up to 24 hours, mid-term: 24 hours to less than 6 months, and long term: more than 6 months).
Of the 1799 patients, 61% were men and 47.08% had history of smoking (75% of the smokers were men). At the time of index PCI, smokers were significantly younger than nonsmokers. Also, MACE were significantly higher in smokers than nonsmokers, which was particularly pronounced at the long-term interval. In the nonsmokers group, there was no difference in MACE occurrence between men and women. However, of the smokers, women showed significantly higher MACE rate compared with men peers.
Smoking makes women more prone to MACE in comparison to men among patients with stable CAD after PCI with drug-eluting stent.
几十年来,心血管疾病(CVD)一直被认为是男性疾病。然而,最近的研究表明,它们在女性中更为常见。吸烟是 CVD 的一个强烈危险因素,尤其是冠心病(CAD)。一些研究报告称,女性比男性更容易受到吸烟的严重后果影响。关于吸烟对经皮冠状动脉介入治疗(PCI)后性别分层的不良临床事件的影响,数据有限。本研究旨在探讨吸烟史患者中,性别是否显著改变 PCI 后不良临床结局的发生率。
参与者从 2003 年至 2019 年从两家医院中选取。在接受 PCI(索引 PCI)的患者中,选择接受择期 PCI 的稳定 CAD 患者。排除标准为直接 PCI 和多次血运重建的患者。根据索引 PCI 时间,在三个时间间隔内(短期:24 小时内,中期:24 小时至 6 个月内,长期:6 个月以上),随访主要不良心脏事件(MACE),包括血运重建(PCI 或冠状动脉旁路移植术)、心肌梗死和冠状动脉死亡。
在 1799 名患者中,61%为男性,47.08%有吸烟史(75%的吸烟者为男性)。在索引 PCI 时,吸烟者明显比不吸烟者年轻。而且,吸烟者的 MACE 发生率明显高于不吸烟者,尤其是在长期间隔时。在不吸烟者组中,男性和女性的 MACE 发生率无差异。然而,在吸烟者中,女性的 MACE 发生率明显高于男性。
与男性相比,在经药物洗脱支架 PCI 治疗稳定 CAD 后,吸烟使女性更容易发生 MACE。